• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CMAJ Anosmia and Dysgeusia Associated With SARS-CoV-2 Infection: An Age-Matched Case-Control Study

tetano

Editor, Senior Moderator
CMAJ


. 2020 May 27;cmaj.200869.
doi: 10.1503/cmaj.200869. Online ahead of print.
Anosmia and Dysgeusia Associated With SARS-CoV-2 Infection: An Age-Matched Case-Control Study


Alex Carignan[SUP] 1 [/SUP], Louis Valiquette[SUP] 1 [/SUP], Cynthia Grenier[SUP] 1 [/SUP], Jean Berchmans Musonera[SUP] 1 [/SUP], Delphin Nkengurutse[SUP] 1 [/SUP], Ana?s Marcil-H?guy[SUP] 1 [/SUP], Kim Vettese[SUP] 1 [/SUP], Dominique Marcoux[SUP] 1 [/SUP], Corinne Valiquette[SUP] 1 [/SUP], Wei Ting Xiong[SUP] 1 [/SUP], Pierre-Hughes Fortier[SUP] 1 [/SUP], M?lissa G?n?reux[SUP] 1 [/SUP], Jacques P?pin[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Anosmia and dysgeusia have been reported as potential symptoms of coronavirus disease 2019. This study aimed to confirm whether anosmia and dysgeusia are specific symptoms among those who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Methods: We conducted an age-matched case-control study in the Eastern Townships region of Quebec between Mar. 10 and Mar. 23, 2020. We included adults (age ≥ 18 yr) who tested positive for SARS-CoV-2 by reverse transcription polymerase chain reaction. Cases were matched (1:1) according to 5-year age groups with control patents selected randomly from among all patients who tested negative for SARS-CoV-2 during the same period. Demographic and laboratory information was collected from medical records. Clinical symptoms and comorbidities associated with anosmia and dysgeusia were obtained by telephone interview with a standardized questionnaire.
Results: Among 2883 people tested for SARS-CoV-2, we identified 134 positive cases (70 women [52.2%] and 64 men [47.8%]; median age 57.1 [interquartile range 41.2-64.5] yr). The symptoms independently associated with SARS-CoV-2 positivity in conditional logistic regression were anosmia or dysgeusia or both (adjusted odds ratio [OR] 62.9, 95% confidence interval [CI] 11.0-359.7), presence of myalgia (adjusted OR 7.6, 95% CI 1.9-29.9), blurred vision (adjusted OR 0.1, 95% CI 0.0-0.8) and chest pain (adjusted OR 0.1, 95% CI 0.0-0.6).
Interpretation: We found a strong association between olfactory and gustatory symptoms and SARS-CoV-2 positivity. These symptoms should be considered as common and distinctive features of SARS-CoV-2 infection and should serve as an indication for testing and possible retesting of people whose first test result is negative.
 
Back
Top Bottom